These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 24941461)

  • 1. Alginate-coated chitosan nanogels differentially modulate class-A and class-B CpG-ODN targeting of dendritic cells and intracellular delivery.
    Démoulins T; Milona P; McCullough KC
    Nanomedicine; 2014 Nov; 10(8):1739-49. PubMed ID: 24941461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alginate-coated chitosan nanogel capacity to modulate the effect of TLR ligands on blood dendritic cells.
    Démoulins T; Bassi I; Thomann-Harwood L; Jandus C; Kaeuper P; Simon HU; von Gunten S; McCullough KC
    Nanomedicine; 2013 Aug; 9(6):806-17. PubMed ID: 23347894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alginate coated chitosan nanoparticles are an effective subcutaneous adjuvant for hepatitis B surface antigen.
    Borges O; Silva M; de Sousa A; Borchard G; Junginger HE; Cordeiro-da-Silva A
    Int Immunopharmacol; 2008 Dec; 8(13-14):1773-80. PubMed ID: 18801462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation, characterization and immunological evaluation of alginate nanoparticles loaded with whole inactivated influenza virus: Dry powder formulation for nasal immunization in rabbits.
    Dehghan S; Kheiri MT; Abnous K; Eskandari M; Tafaghodi M
    Microb Pathog; 2018 Feb; 115():74-85. PubMed ID: 29223454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attachment of class B CpG ODN onto DOTAP/DC-chol liposome in nasal vaccine formulations augments antigen-specific immune responses in mice.
    Tada R; Muto S; Iwata T; Hidaka A; Kiyono H; Kunisawa J; Aramaki Y
    BMC Res Notes; 2017 Jan; 10(1):68. PubMed ID: 28126014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of systemic and mucosal immune responses by intranasal administration of alginate microspheres encapsulated with tetanus toxoid and CpG-ODN.
    Tafaghodi M; Sajadi Tabassi SA; Jaafari MR
    Int J Pharm; 2006 Aug; 319(1-2):37-43. PubMed ID: 16701972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CpG-B ODNs potently induce low levels of IFN-alphabeta and induce IFN-alphabeta-dependent MHC-I cross-presentation in DCs as effectively as CpG-A and CpG-C ODNs.
    Gray RC; Kuchtey J; Harding CV
    J Leukoc Biol; 2007 Apr; 81(4):1075-85. PubMed ID: 17227820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunostimulatory Properties of Lipid Modified CpG Oligonucleotides.
    Yu C; An M; Li M; Liu H
    Mol Pharm; 2017 Aug; 14(8):2815-2823. PubMed ID: 28686452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivery by cationic gelatin nanoparticles strongly increases the immunostimulatory effects of CpG oligonucleotides.
    Zwiorek K; Bourquin C; Battiany J; Winter G; Endres S; Hartmann G; Coester C
    Pharm Res; 2008 Mar; 25(3):551-62. PubMed ID: 17912489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of oligodeoxyribonucleotides that induce interferon (IFN)-alpha in the pig and the phenotype of the IFN-alpha producing cells.
    Domeika K; Magnusson M; Eloranta ML; Fuxler L; Alm GV; Fossum C
    Vet Immunol Immunopathol; 2004 Sep; 101(1-2):87-102. PubMed ID: 15261695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CpG-B oligodeoxynucleotides inhibit TLR-dependent and -independent induction of type I IFN in dendritic cells.
    Liu YC; Gray RC; Hardy GA; Kuchtey J; Abbott DW; Emancipator SN; Harding CV
    J Immunol; 2010 Apr; 184(7):3367-76. PubMed ID: 20181884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells.
    Krug A; Rothenfusser S; Hornung V; Jahrsdörfer B; Blackwell S; Ballas ZK; Endres S; Krieg AM; Hartmann G
    Eur J Immunol; 2001 Jul; 31(7):2154-63. PubMed ID: 11449369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low molecular weight chitosan nanoparticles for CpG oligodeoxynucleotides delivery: Impact of molecular weight, degree of deacetylation, and mannosylation on intracellular uptake and cytokine induction.
    Babii O; Wang Z; Liu G; Martinez EC; van Drunen Littel-van den Hurk S; Chen L
    Int J Biol Macromol; 2020 Sep; 159():46-56. PubMed ID: 32437810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbonate Apatite Nanoparticles Act as Potent Vaccine Adjuvant Delivery Vehicles by Enhancing Cytokine Production Induced by Encapsulated Cytosine-Phosphate-Guanine Oligodeoxynucleotides.
    Takahashi H; Misato K; Aoshi T; Yamamoto Y; Kubota Y; Wu X; Kuroda E; Ishii KJ; Yamamoto H; Yoshioka Y
    Front Immunol; 2018; 9():783. PubMed ID: 29720976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of alginate coated chitosan microparticles for vaccine delivery.
    Li X; Kong X; Shi S; Zheng X; Guo G; Wei Y; Qian Z
    BMC Biotechnol; 2008 Nov; 8():89. PubMed ID: 19019229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The enhanced antitumor-specific immune response with mannose- and CpG-ODN-coated liposomes delivering TRP2 peptide.
    Lai C; Duan S; Ye F; Hou X; Li X; Zhao J; Yu X; Hu Z; Tang Z; Mo F; Yang X; Lu X
    Theranostics; 2018; 8(6):1723-1739. PubMed ID: 29556352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid Nanoparticles Potentiate CpG-Oligodeoxynucleotide-Based Vaccine for Influenza Virus.
    Shirai S; Shibuya M; Kawai A; Tamiya S; Munakata L; Omata D; Suzuki R; Aoshi T; Yoshioka Y
    Front Immunol; 2019; 10():3018. PubMed ID: 31998305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-dependent immunostimulatory effect of CpG oligodeoxynucleotides and their delivery system.
    Hanagata N
    Int J Nanomedicine; 2012; 7():2181-95. PubMed ID: 22619554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physical, Chemical, and Biological Properties of Chitosan-Coated Alginate Microparticles Loaded with Porcine Interleukin-1β: A Potential Protein Adjuvant Delivery System.
    Ho WX; Chen WT; Lien CH; Yang HY; Chen KH; Wei YF; Wang MH; Ko IT; Tseng FG; Yin HS
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioreducible alginate-poly(ethylenimine) nanogels as an antigen-delivery system robustly enhance vaccine-elicited humoral and cellular immune responses.
    Li P; Luo Z; Liu P; Gao N; Zhang Y; Pan H; Liu L; Wang C; Cai L; Ma Y
    J Control Release; 2013 Jun; 168(3):271-9. PubMed ID: 23562637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.